
[Expand/Collapse all sections]Expand all

For information on how to process a PBS Authority, see Processing
Complex Authority Required Listings. Contact a Local Peer Support (LPS)
if unsure on how to action an application.

On this page:

Crohn's disease (adult) quick reference

Table 1

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | level and | a         | rocessing | rescriber | rescriber |
|           | section   | ssessment | system    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | Yes       | OPA       | Must be   | No        |
|           |           |           |           | treated   |           |
| PB087     | S85:      |           | Database  | by a:     |           |
| form      | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
|           | i         |           |           | Gastroent |           |
|           | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           | us        |           |           | onsultant |           |
|           | tekinumab |           |           |           |           |
|           | ve        |           |           | physician |           |
|           | dolizumab |           |           |           |           |
|           | s.c.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |  medicine |           |
|           | i         |           |           |     spe   |           |
|           | nfliximab |           |           | cialising |           |
|           | i.v.      |           |           |     in    |           |
|           | us        |           |           |           |           |
|           | tekinumab |           |           |  gastroen |           |
|           | ve        |           |           | terology) |           |
|           | dolizumab |           |           | -   C     |           |
|           | s.c.      |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Change or | Written   | Yes       | OPA       | Must be   | No        |
| Recom     |           |           |           | treated   |           |
| mencement | S85:      |           | Database  | by a:     |           |
| after a   | a         |           |           |           |           |
| break     | dalimumab |           |           | -         |           |
|           | i         |           |           | Gastroent |           |
| (<5       | nfliximab |           |           | erologist |           |
| years)    | s.c.      |           |           | -   C     |           |
|           | us        |           |           | onsultant |           |
| Or        | tekinumab |           |           |           |           |
|           | ve        |           |           | physician |           |
| Recom     | dolizumab |           |           |           |           |
| mencement | s.c.      |           |           | (internal |           |
| after a   |           |           |           |           |           |
| break (>5 | S100:     |           |           |  medicine |           |
| years)    | i         |           |           |     spe   |           |
|           | nfliximab |           |           | cialising |           |
| PB235     | i.v.      |           |           |     in    |           |
| form      | us        |           |           |           |           |
|           | tekinumab |           |           |  gastroen |           |
|           | ve        |           |           | terology) |           |
|           | dolizumab |           |           | -   C     |           |
|           | i.v.      |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| First     | Written   | No        | OPA       | Must be   | No        |
| c         |           |           |           | treated   |           |
| ontinuing | S85:      |           | Database  | by a:     |           |
|           | a         |           |           |           |           |
| PB088     | dalimumab |           |           | -         |           |
| form      | i         |           |           | Gastroent |           |
|           | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           | us        |           |           | onsultant |           |
|           | tekinumab |           |           |           |           |
|           | ve        |           |           | physician |           |
|           | dolizumab |           |           |           |           |
|           | s.c.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |  medicine |           |
|           | i         |           |           |     spe   |           |
|           | nfliximab |           |           | cialising |           |
|           | i.v.      |           |           |     in    |           |
|           | ve        |           |           |           |           |
|           | dolizumab |           |           |  gastroen |           |
|           | i.v.      |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| S         | Written   | No        | OPA       | Must be   | No        |
| ubsequent |           |           |           | treated   |           |
| c         | S85:      |           | Database  | by a:     |           |
| ontinuing | a         |           |           |           |           |
| -         | dalimumab |           |           | -         |           |
|           | i         |           |           | Gastroent |           |
| O         | nfliximab |           |           | erologist |           |
| riginator | s.c.      |           |           | -   C     |           |
| brands    | us        |           |           | onsultant |           |
|           | tekinumab |           |           |           |           |
| PB088     | ve        |           |           | physician |           |
| form      | dolizumab |           |           |           |           |
|           | s.c.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |  medicine |           |
|           | i         |           |           |     spe   |           |
|           | nfliximab |           |           | cialising |           |
|           | i.v.      |           |           |     in    |           |
|           | ve        |           |           |           |           |
|           | dolizumab |           |           |  gastroen |           |
|           | i.v.      |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| S         | St        | N/A       | N/A       | Must be   | N/A       |
| ubsequent | reamlined |           |           | treated   |           |
| c         |           |           |           | by a:     |           |
| ontinuing | S85:      |           |           |           |           |
| –         | a         |           |           | -         |           |
| B         | dalimumab |           |           | Gastroent |           |
| iosimilar |           |           |           | erologist |           |
| brands    | S100:     |           |           | -   C     |           |
|           | i         |           |           | onsultant |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | physician |           |
|           |           |           |           |           |           |
|           | (         |           |           | (internal |           |
|           | Telephone |           |           |           |           |
|           | for       |           |           |  medicine |           |
|           | increased |           |           |     spe   |           |
|           | q         |           |           | cialising |           |
|           | uantities |           |           |     in    |           |
|           | of        |           |           |           |           |
|           | i         |           |           |  gastroen |           |
|           | nfliximab |           |           | terology) |           |
|           | i.v. for  |           |           | -   C     |           |
|           | patien    |           |           | onsultant |           |
|           | ts>100kg) |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Balance   | Telephone | No        | OPA       | Must be   | Yes       |
| of supply |           |           |           | treated   |           |
|           | E         |           |           | by a:     |           |
| (top-up)  | lectronic |           |           |           |           |
|           |           |           |           | -         |           |
|           | S85:      |           |           | Gastroent |           |
|           | a         |           |           | erologist |           |
|           | dalimumab |           |           | -   C     |           |
|           | i         |           |           | onsultant |           |
|           | nfliximab |           |           |           |           |
|           | s.c.      |           |           | physician |           |
|           | us        |           |           |           |           |
|           | tekinumab |           |           | (internal |           |
|           | ve        |           |           |           |           |
|           | dolizumab |           |           |  medicine |           |
|           | s.c.      |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           | S100:     |           |           |     in    |           |
|           | i         |           |           |           |           |
|           | nfliximab |           |           |  gastroen |           |
|           | i.v.      |           |           | terology) |           |
|           | ve        |           |           | -   C     |           |
|           | dolizumab |           |           | onsultant |           |
|           | i.v.      |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Demo      | Written   | No        | Database  | Must be   | No        |
| nstration |           |           |           | treated   |           |
| of        | S85:      |           |           | by a:     |           |
| response  | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
| PB235     | i         |           |           | Gastroent |           |
| form      | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           | us        |           |           | onsultant |           |
|           | tekinumab |           |           |           |           |
|           | ve        |           |           | physician |           |
|           | dolizumab |           |           |           |           |
|           | s.c.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |  medicine |           |
|           | i         |           |           |     spe   |           |
|           | nfliximab |           |           | cialising |           |
|           | i.v.      |           |           |     in    |           |
|           | us        |           |           |           |           |
|           | tekinumab |           |           |  gastroen |           |
|           | ve        |           |           | terology) |           |
|           | dolizumab |           |           | -   C     |           |
|           | i.v.      |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Medical   | Written   | Yes       | Database  | Must be   | No        |
| break     |           |           |           | treated   |           |
|           | S85:      |           |           | by a:     |           |
|           | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
|           | i         |           |           | Gastroent |           |
|           | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           | us        |           |           | onsultant |           |
|           | tekinumab |           |           |           |           |
|           | ve        |           |           | physician |           |
|           | dolizumab |           |           |           |           |
|           | s.c.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |  medicine |           |
|           | i         |           |           |     spe   |           |
|           | nfliximab |           |           | cialising |           |
|           | i.v.      |           |           |     in    |           |
|           | us        |           |           |           |           |
|           | tekinumab |           |           |  gastroen |           |
|           | ve        |           |           | terology) |           |
|           | dolizumab |           |           | -   C     |           |
|           | i.v.      |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

Fistulising Crohn's disease quick reference

Table 2

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | level and | a         | rocessing | rescriber | rescriber |
|           | section   | ssessment | system    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | Yes       | OPA       | Must be   | No        |
| or        |           |           |           | treated   |           |
| Recom     | S85:      |           | Database  | by a:     |           |
| mencement | a         |           |           |           |           |
| after a   | dalimumab |           |           | -         |           |
| break (>5 | i         |           |           | Gastroent |           |
| years)    | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
| PB092     |           |           |           | onsultant |           |
| form      | S100:     |           |           |           |           |
|           | i         |           |           | physician |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Change or | Written   | Yes       | OPA       | Must be   | No        |
| Recom     |           |           |           | treated   |           |
| mencement | S85:      |           | Database  | by a:     |           |
| after a   | a         |           |           |           |           |
| break (<5 | dalimumab |           |           | -         |           |
| years)    | i         |           |           | Gastroent |           |
|           | nfliximab |           |           | erologist |           |
| PB236     | s.c.      |           |           | -   C     |           |
| form      |           |           |           | onsultant |           |
|           | S100:     |           |           |           |           |
|           | i         |           |           | physician |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| First     | Written   | No        | OPA       | Must be   | No        |
| c         |           |           |           | treated   |           |
| ontinuing | S85:      |           | Database  | by a:     |           |
|           | a         |           |           |           |           |
| PB093     | dalimumab |           |           | -         |           |
| form      | i         |           |           | Gastroent |           |
|           | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           | S100:     |           |           |           |           |
|           | i         |           |           | physician |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| S         | Written   | No        | OPA       | Must be   | No        |
| ubsequent |           |           |           | treated   |           |
| c         | S85:      |           | Database  | by a:     |           |
| ontinuing | a         |           |           |           |           |
| -         | dalimumab |           |           | -         |           |
|           | i         |           |           | Gastroent |           |
| O         | nfliximab |           |           | erologist |           |
| riginator | s.c.      |           |           | -   C     |           |
| brands    |           |           |           | onsultant |           |
|           | S100:     |           |           |           |           |
| PB093     | i         |           |           | physician |           |
| form      | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| S         | St        | N/A       | N/A       | Must be   | N/A       |
| ubsequent | reamlined |           |           | treated   |           |
| c         |           |           |           | by a:     |           |
| ontinuing | S85:      |           |           |           |           |
| –         | a         |           |           | -         |           |
| B         | dalimumab |           |           | Gastroent |           |
| iosimilar |           |           |           | erologist |           |
| brands    | S100:     |           |           | -   C     |           |
|           | i         |           |           | onsultant |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | physician |           |
|           |           |           |           |           |           |
|           | (         |           |           | (internal |           |
|           | Telephone |           |           |           |           |
|           | for       |           |           |  medicine |           |
|           | increased |           |           |     spe   |           |
|           | q         |           |           | cialising |           |
|           | uantities |           |           |     in    |           |
|           | of        |           |           |           |           |
|           | i         |           |           |  gastroen |           |
|           | nfliximab |           |           | terology) |           |
|           | i.v. for  |           |           | -   C     |           |
|           | patien    |           |           | onsultant |           |
|           | ts>100kg) |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Balance   | Telephone | No        | OPA       | Must be   | Yes       |
| of supply |           |           |           | treated   |           |
|           | E         |           |           | by a:     |           |
| (top-up)  | lectronic |           |           |           |           |
|           |           |           |           | -         |           |
|           | S85:      |           |           | Gastroent |           |
|           | a         |           |           | erologist |           |
|           | dalimumab |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           | I         |           |           |           |           |
|           | nfliximab |           |           | physician |           |
|           | s.c.      |           |           |           |           |
|           |           |           |           | (internal |           |
|           | S100:     |           |           |           |           |
|           | i         |           |           |  medicine |           |
|           | nfliximab |           |           |     spe   |           |
|           | i.v.      |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Demo      | Written   | No        | Database  | Must be   | No        |
| nstration |           |           |           | treated   |           |
| of        | S85:      |           |           | by a:     |           |
| response  | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
| PB236     | i         |           |           | Gastroent |           |
| form      | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           | S100:     |           |           |           |           |
|           | i         |           |           | physician |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Medical   | Written   | Yes       | Database  | Must be   | No        |
| Break     |           |           |           | treated   |           |
|           | S85:      |           |           | by a:     |           |
|           | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
|           | i         |           |           | Gastroent |           |
|           | nfliximab |           |           | erologist |           |
|           | s.c.      |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           | S100:     |           |           |           |           |
|           | i         |           |           | physician |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

Crohn's disease (paediatric) quick reference

Table 3

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | level and | a         | rocessing | rescriber | rescriber |
|           | section   | ssessment | system    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | Yes       | OPA       | Must be   | No        |
|           |           |           |           | treated   |           |
| PB085     | S85:      |           | Database  | by a:     |           |
| form      | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
|           |           |           |           | Gastroent |           |
|           | S100:     |           |           | erologist |           |
|           | i         |           |           | -   C     |           |
|           | nfliximab |           |           | onsultant |           |
|           | i.v.      |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Change or | Written   | Yes       | OPA       | Must be   | No        |
| Recom     |           |           |           | treated   |           |
| mencement | S85:      |           | Database  | by a:     |           |
| after a   | a         |           |           |           |           |
| break (<  | dalimumab |           |           | -         |           |
| 5 years)  |           |           |           | Gastroent |           |
|           | S100:     |           |           | erologist |           |
| or        | i         |           |           | -   C     |           |
|           | nfliximab |           |           | onsultant |           |
| Recom     | i.v.      |           |           |           |           |
| mencement |           |           |           | physician |           |
| after a   |           |           |           |           |           |
| break     |           |           |           | (internal |           |
|           |           |           |           |           |           |
| (>5       |           |           |           |  medicine |           |
| years)    |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
| PB239     |           |           |           |     in    |           |
| form      |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| First     | Written   | No        | OPA       | Must be   | No        |
| c         |           |           |           | treated   |           |
| ontinuing | S85:      |           | Database  | by a:     |           |
|           | a         |           |           |           |           |
| PB161     | dalimumab |           |           | -         |           |
| form      |           |           |           | Gastroent |           |
|           | S100:     |           |           | erologist |           |
|           | i         |           |           | -   C     |           |
|           | nfliximab |           |           | onsultant |           |
|           | i.v.      |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| S         | Written   | No        | OPA       | Must be   | No        |
| ubsequent |           |           |           | treated   |           |
| c         | S85:      |           | Database  | by a:     |           |
| ontinuing | a         |           |           |           |           |
| -         | dalimumab |           |           | -         |           |
|           |           |           |           | Gastroent |           |
| O         | S100:     |           |           | erologist |           |
| riginator | i         |           |           | -   C     |           |
| brands    | nfliximab |           |           | onsultant |           |
|           | i.v.      |           |           |           |           |
| PB161     |           |           |           | physician |           |
| form      |           |           |           |           |           |
|           |           |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| S         | St        | N/A       | N/A       | Must be   | N/A       |
| ubsequent | reamlined |           |           | treated   |           |
| c         |           |           |           | by a:     |           |
| ontinuing | S85:      |           |           |           |           |
| -         | a         |           |           | -         |           |
|           | dalimumab |           |           | Gastroent |           |
| B         |           |           |           | erologist |           |
| iosimilar | S100:     |           |           | -   C     |           |
| brands    | i         |           |           | onsultant |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | physician |           |
|           |           |           |           |           |           |
|           | (         |           |           | (internal |           |
|           | Telephone |           |           |           |           |
|           | for       |           |           |  medicine |           |
|           | increased |           |           |     spe   |           |
|           | q         |           |           | cialising |           |
|           | uantities |           |           |     in    |           |
|           | of        |           |           |           |           |
|           | i         |           |           |  gastroen |           |
|           | nfliximab |           |           | terology) |           |
|           | i.v. for  |           |           | -   C     |           |
|           | patien    |           |           | onsultant |           |
|           | ts>100kg) |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Balance   | Telephone | No        | OPA       | Must be   | Yes       |
| of supply |           |           |           | treated   |           |
|           | E         |           |           | by a:     |           |
| (top-up)  | lectronic |           |           |           |           |
|           |           |           |           | -         |           |
|           | S85:      |           |           | Gastroent |           |
|           | a         |           |           | erologist |           |
|           | dalimumab |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           | S100:     |           |           |           |           |
|           | i         |           |           | physician |           |
|           | nfliximab |           |           |           |           |
|           | i.v.      |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Demo      | Written   | No        | Database  | Must be   | No        |
| nstration |           |           |           | treated   |           |
| of        | S85:      |           |           | by a:     |           |
| response  | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
| PB239     |           |           |           | Gastroent |           |
| form      | S100:     |           |           | erologist |           |
|           | i         |           |           | -   C     |           |
|           | nfliximab |           |           | onsultant |           |
|           | i.v.      |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Medical   | Written   | Yes       | Database  | Must be   | No        |
| Break     |           |           |           | treated   |           |
|           | S85:      |           |           | by a:     |           |
|           | a         |           |           |           |           |
|           | dalimumab |           |           | -         |           |
|           |           |           |           | Gastroent |           |
|           | S100:     |           |           | erologist |           |
|           | i         |           |           | -   C     |           |
|           | nfliximab |           |           | onsultant |           |
|           | i.v.      |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           | (internal |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   C     |           |
|           |           |           |           | onsultant |           |
|           |           |           |           |           |           |
|           |           |           |           | physician |           |
|           |           |           |           |           |           |
|           |           |           |           |  (general |           |
|           |           |           |           |           |           |
|           |           |           |           |  medicine |           |
|           |           |           |           |     spe   |           |
|           |           |           |           | cialising |           |
|           |           |           |           |     in    |           |
|           |           |           |           |           |           |
|           |           |           |           |  gastroen |           |
|           |           |           |           | terology) |           |
|           |           |           |           | -   Paed  |           |
|           |           |           |           | iatrician |           |
|           |           |           |           |     or a  |           |
|           |           |           |           |     s     |           |
|           |           |           |           | pecialist |           |
|           |           |           |           |     p     |           |
|           |           |           |           | aediatric |           |
|           |           |           |           |           |           |
|           |           |           |           | gastroent |           |
|           |           |           |           | erologist |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

Applications completed on the database

Table 4

+-----------------------------------+-----------------------------------+
| Application Type                  | Action                            |
+-----------------------------------+-----------------------------------+
| Initial                           | -   Create a patient record on    |
|                                   |     the database if required      |
|                                   | -   Create a new pended entry in  |
|                                   |     the database                  |
|                                   | -   Send to a Pharmaceutical      |
|                                   |     Advisor (PA) for assessment   |
|                                   |                                   |
|                                   | Once the application has been     |
|                                   | assessed by PA complete the entry |
|                                   | in the database.                  |
+-----------------------------------+-----------------------------------+
| First continuing                  | If approved:                      |
|                                   |                                   |
|                                   | -   Create and complete an entry  |
|                                   |     in the database               |
|                                   | -   Enter the Next Assessment     |
|                                   |     Date                          |
+-----------------------------------+-----------------------------------+
| Subsequent continuing             | -   No line in the database       |
|                                   |     required                      |
|                                   | -   If approved, enter the Next   |
|                                   |     Assessment Date               |
+-----------------------------------+-----------------------------------+
| Change or Recommencement          | -   Create a new pended entry in  |
|                                   |     the database                  |
|                                   | -   Send to a PA for assessment   |
|                                   |                                   |
|                                   | Once the application has been     |
|                                   | assessed by PA complete the entry |
|                                   | in the database.                  |
+-----------------------------------+-----------------------------------+
| Balance of Supply                 | No database entry required.       |
+-----------------------------------+-----------------------------------+
| Demonstration of Response         | -   Create and complete a new     |
|                                   |     entry in the database         |
|                                   | -   Update the drug history       |
|                                   |                                   |
|                                   |                                   |
+-----------------------------------+-----------------------------------+
| Medical break                     | -   Create a new pended entry in  |
|                                   |     the database                  |
|                                   | -   Send to a PA to action        |
+-----------------------------------+-----------------------------------+

First continuing applications

Table 5

+-----------------------------------+-----------------------------------+
| Assess up to 12 weeks of          | Assess after 12 weeks of          |
| treatments                        | treatment                         |
+-----------------------------------+-----------------------------------+
| -    Infliximab i.v.              | -   Adalimumab (Humira &          |
|                                   |     biosimilars) – CD adult, CD   |
|    (Remicade/Inflectra/Renflexis) |     paediatric and FCD patients   |
|     – CD adult, CD paediatric and | -   Infliximab s.c. (Remsima)     |
|     FCD patients                  |     with infliximab i.v. loading  |
| -   Vedolizumab i.v. (Entyvio IV) |     – CD adult and FCD patients   |
|     – CD adult patients           | -   Ustekinumab (Stelara) – CD    |
|                                   |     adult patients                |
|                                   | -   Vedolizumab s.c. (Entyvio SC) |
|                                   |     – CD adult patients           |
+-----------------------------------+-----------------------------------+

Current treatment for subsequent continuing applications

Table 6

+-----------------------+-----------------------+-----------------------+
| Step                  | Action                | Result                |
+-----------------------+-----------------------+-----------------------+
| 1                     | Is the previous Next  | -   Yes - Approve     |
|                       | Assessment Date       | -   No - Go to Step 2 |
|                       | within 3 months of    |                       |
|                       | ‘date of processing’? |                       |
+-----------------------+-----------------------+-----------------------+
| 2                     | Is the application a  | -   Yes - Approve     |
|                       | subsequent continuing | -   No - Go to Step 3 |
|                       | for a drug with a     |                       |
|                       | biosimilar brand      |                       |
|                       | listing?              |                       |
+-----------------------+-----------------------+-----------------------+
| 3                     | Has the prescriber    | -   Yes - Approve     |
|                       | completed ‘current    | -   No - Go to Step 4 |
|                       | treatment’ or         |                       |
|                       | provided dates of     |                       |
|                       | most recent treatment |                       |
|                       | course on the         |                       |
|                       | application form?     |                       |
+-----------------------+-----------------------+-----------------------+
| 4                     | Check dispensing      | -   Yes - Approve     |
|                       | history. Is there a   | -   No - Go to Step 5 |
|                       | dispensing in the     |                       |
|                       | last 3 months?        |                       |
+-----------------------+-----------------------+-----------------------+
| 5                     | Is there a letter or  | -   Yes - Refer to a  |
|                       | note from the         |     PA                |
|                       | prescriber regarding  | -   No – Reject       |
|                       | a break in treatment? |                       |
+-----------------------+-----------------------+-----------------------+

                                   

-   Services Australia ABN 90 794 605 008 
